Literature DB >> 26324745

Spike rate of multi-unit muscle sympathetic nerve fibers after catheter-based renal nerve ablation.

Jens Tank1, Karsten Heusser1, Julia Brinkmann1, Bernhard M Schmidt2, Jan Menne2, Johann Bauersachs3, Hermann Haller2, André Diedrich4, Jens Jordan5.   

Abstract

Patients with treatment-resistant arterial hypertension exhibited profound reductions in single sympathetic vasoconstrictor fiber firing rates after renal nerve ablation. In contrast, integrated multi-unit muscle sympathetic nerve activity (MSNA) changed little or not at all. We hypothesized that conventional MSNA analysis may have missed single fiber discharges, thus, obscuring sympathetic inhibition after renal denervation. We studied patients with difficult-to-control arterial hypertension (age 45-74 years) before, 6 (n = 11), and 12 months (n = 8) after renal nerve ablation. Electrocardiogram, respiration, brachial, and finger arterial blood pressure (BP), as well as the MSNA and raw MSNA signals were analyzed. We detected MSNA action-potential spikes using 2 stage kurtosis wavelet denoising techniques to assess mean, median, and maximum spike rates for each beat-to-beat interval. Supine heart rate and systolic BP did not change at 6 (ΔHR: -2 ± 3 bpm; ΔSBP: 2 ± 9 mm Hg) or at 12 months (ΔHR: -1 ± 3 mm Hg, ΔSBP: -1 ± 9 mm Hg) after renal nerve ablation. Mean burst frequency and mean spike frequency at baseline were 34 ± 3 bursts per minute and 8 ± 1 spikes per second. Both measurements did not change at 6 months (-1.4 ± 3.6 bursts/minute; -0.6 ± 1.4 spikes/second) or at 12 months (-2.5 ± 4.0 bursts/minute; -2.0 ± 1.6 spikes/second) after renal nerve ablation. After renal nerve ablation, BP decreased in 3 of 11 patients. BP and MSNA spike frequency changes were not correlated (slope = -0.06; P = .369). Spike rate analysis of multi-unit MSNA neurograms further suggests that profound sympathetic inhibition is not a consistent finding after renal nerve ablation.
Copyright © 2015 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arterial hypertension; blood pressure; microneurography; renal denervation

Mesh:

Year:  2015        PMID: 26324745      PMCID: PMC4785601          DOI: 10.1016/j.jash.2015.07.012

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  33 in total

1.  The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients.

Authors:  E E Vink; W L Verloop; L Siddiqi; L J van Schelven; P Liam Oey; P J Blankestijn
Journal:  Int J Cardiol       Date:  2014-06-28       Impact factor: 4.164

2.  Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep.

Authors:  Lindsea C Booth; Erika E Nishi; Song T Yao; Rohit Ramchandra; Gavin W Lambert; Markus P Schlaich; Clive N May
Journal:  Hypertension       Date:  2014-11-17       Impact factor: 10.190

3.  Blood pressure responses to renal denervation precede and are independent of the sympathetic and baroreflex effects.

Authors:  Guido Grassi; Gino Seravalle; Gianmaria Brambilla; Daniela Trabattoni; Cesare Cuspidi; Rocco Corso; Federico Pieruzzi; Simonetta Genovesi; Andrea Stella; Rita Facchetti; Domenico Spaziani; Antonio Bartorelli; Giuseppe Mancia
Journal:  Hypertension       Date:  2015-03-30       Impact factor: 10.190

4.  Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension.

Authors:  Dagmara Hering; Elisabeth A Lambert; Petra Marusic; Antony S Walton; Henry Krum; Gavin W Lambert; Murray D Esler; Markus P Schlaich
Journal:  Hypertension       Date:  2012-11-19       Impact factor: 10.190

5.  Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.

Authors:  Dagmara Hering; Petra Marusic; Antony S Walton; Elisabeth A Lambert; Henry Krum; Krzysztof Narkiewicz; Gavin W Lambert; Murray D Esler; Markus P Schlaich
Journal:  Hypertension       Date:  2014-04-14       Impact factor: 10.190

6.  Firing patterns of muscle sympathetic neurons during short-term use of continuous positive airway pressure in healthy subjects and in chronic heart failure patients.

Authors:  Petra Zubin Maslov; Toni Breskovic; J Kevin Shoemaker; Thomas P Olson; Bruce D Johnson; Davor Eterovic; Zeljko Dujic
Journal:  Respir Physiol Neurobiol       Date:  2013-03-26       Impact factor: 1.931

7.  Sympathetic nerve activity in end-stage renal disease.

Authors:  Martin Hausberg; Markus Kosch; Patrick Harmelink; Michael Barenbrock; Helge Hohage; Klaus Kisters; Karl Heinz Dietl; Karl Heinz Rahn
Journal:  Circulation       Date:  2002-10-08       Impact factor: 29.690

8.  Paradoxical muscle sympathetic reflex activation in human heart failure.

Authors:  Philip J Millar; Hisayoshi Murai; John S Floras
Journal:  Circulation       Date:  2014-12-02       Impact factor: 29.690

9.  Mechanisms of sympathoexcitation: single-unit analysis of muscle vasoconstrictor neurons in awake OSAS subjects.

Authors:  Mikael Elam; David McKenzie; Vaughan Macefield
Journal:  J Appl Physiol (1985)       Date:  2002-07

10.  A controlled trial of renal denervation for resistant hypertension.

Authors:  Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris
Journal:  N Engl J Med       Date:  2014-03-29       Impact factor: 91.245

View more
  2 in total

1.  Integrative Blood Pressure Response to Upright Tilt Post Renal Denervation.

Authors:  Erin J Howden; Cara East; Justin S Lawley; Abigail S L Stickford; Myrthe Verhees; Qi Fu; Benjamin D Levine
Journal:  Am J Hypertens       Date:  2017-06-01       Impact factor: 2.689

2.  Vagal and Sympathetic Function in Neuropathic Postural Tachycardia Syndrome.

Authors:  Giris Jacob; Laura Diedrich; Kyoko Sato; Robert J Brychta; Satish R Raj; David Robertson; Italo Biaggioni; André Diedrich
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.